BioCardia (BCDA) Change in Accrued Expenses (2009 - 2026)
BioCardia's Change in Accured Expenses came in at $20,000 for Q2 2026, compared with -$21,000 a year earlier and down 89.8% from the prior quarter.
Powered by 
Analysis
BioCardia (BCDA) Change in Accrued Expenses (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioCardia reported Change in Accured Expenses of -$50,000; for FY2025, it came in at $179,000.
- Change in Accured Expenses carries a five-year compound annual growth rate of -25.8% (FY2020 to FY2025).
- Going back by year, Change in Accured Expenses was -$538,000 in FY2024, $482,000 in FY2023 (+15.9%), $416,000 in FY2022 (+220.0%) and $130,000 in FY2021 (-83.7%).
- The five-year range for quarterly Change in Accured Expenses is -$430,000 (Q2 2024) to $467,000 (Q1 2025).
- The fastest year-over-year change in Change in Accured Expenses over five years came in Q3 2022 (growth of 92.3%), and the weakest in Q1 2026 (a decline of 57.8%).
- Business Quant data shows BCDA's Change in Accured Expenses at $197,000 (Q1 2026), -$73,000 (Q4 2025) and -$194,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | BioCardia | 11.25 Mn | -1.62 Mn | - | 20,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Mar 31, 2026 | 197,000.00 |
| Dec 31, 2025 | -73,000.00 |
| Sep 30, 2025 | -194,000.00 |
| Jun 30, 2025 | -21,000.00 |
| Mar 31, 2025 | 467,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | -366,000.00 |
| Jun 30, 2024 | -430,000.00 |
| Mar 31, 2024 | 311,000.00 |
| Dec 31, 2023 | -116,000.00 |
| Sep 30, 2023 | 245,000.00 |
| Jun 30, 2023 | 127,000.00 |
| Mar 31, 2023 | 226,000.00 |
| Dec 31, 2022 | 151,000.00 |
| Sep 30, 2022 | 352,000.00 |
| Jun 30, 2022 | 114,000.00 |
| Mar 31, 2022 | -201,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 183,000.00 |
API Access
BioCardia Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BCDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "BCDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BCDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();